A5008901785- Pharmaceutical Practices and Patient Outcomes
- Pharmacology and Obesity Treatment
- Diabetes Management and Research
- Diet and metabolism studies
- Metabolism, Diabetes, and Cancer
- Diabetes and associated disorders
- Ginger and Zingiberaceae research
- Systemic Lupus Erythematosus Research
- Electrowetting and Microfluidic Technologies
- Neurological and metabolic disorders
- Pharmaceutical studies and practices
- Celiac Disease Research and Management
- Statistical Methods in Clinical Trials
- Patient Safety and Medication Errors
- Adrenal and Paraganglionic Tumors
- Nursing Roles and Practices
- Liver Disease Diagnosis and Treatment
- Neuroendocrine Tumor Research Advances
- Medication Adherence and Compliance
- Genomics, phytochemicals, and oxidative stress
- Psoriasis: Treatment and Pathogenesis
- Phytochemistry and Biological Activities
- Piperaceae Chemical and Biological Studies
- Diabetes Management and Education
- Pharmacogenetics and Drug Metabolism
King Saud Medical City
2020-2025
King Saud University
2020-2025
Purpose: This study aimed to assess patient activation using measure 13 (PAM-13) in systemic lupus erythematosus (SLE), psoriatic arthritis (PsA), and axial spondyloarthritis (axSPA). Patients methods: A cross-sectional was conducted involving patients with three rheumatological conditions (SLE, PsA, axSPA). were contacted either at the clinic or through social media platforms. Data, including demographics, PAM 13, Arabic compliance questionnaire for rheumatology (ACQR), disease-related...
Diabetes prevalence is estimated to reach 20.6% by 2030. Studies have illustrated main reasons for uncontrolled patients and concluded: low level of awareness, limited access healthcare providers, lack cooperation between different disciplines. The role pharmacists has been proven improve patient-related outcomes, including an improvement in HgA1C readings 0.54% 1.6%.This study was conducted evaluate diabetes-related health outcomes a pharmacist-led diabetes clinic terms HgbA1C level,...
Intern assessment during advanced pharmacy practice experiences (APPEs) are generally based upon each individual preceptor's perceptions without an objective measurement of intern understanding and performance. Therefore, we sought to determine whether a pre- post-OSCE could be used confirm that interns achieved the goals objectives Ambulatory Care rotation. The aims this study were pre-rotation OSCE can help self-assess their clinical strengths weaknesses assess knowledge skills improved...
The present research has demonstrated the impact of treatment with piperine on hepatic fibrosis induced by administration carbon tetrachloride. In order to study outcome caused tetrachloride in male Wistar rats, a total 24 rats were collected and randomly classified into 4 separate groups each consisting 6 animals. Group I was assigned as control group treated olive oil for weeks (1 ml/kg, i.p.) two doses week. II designated toxic 1:1 combination oil, induction III graded therapy co-treated...
Background and Objectives: Globally, diabetes Mellitus (DM) is a life-threatening disease that, if it remains uncontrolled, can lead to mortality or serious complications. Despite the noticeable benefits of clinical pharmacist in managing diabetes, some institutions Saudi Arabia are reluctant establish pharmacist-led diabetic clinic for monitoring follow-up. The objective this study assess glycemic control by comparing reduction hemoglobin A1c (HbA1c) percentage between patients followed...
Background:: Hyperprolactinemia is a commonly underestimated adverse effect of antipsychotic medications. There are still no consensus guidelines for the optimal monitoring and treatment strategies. Objective:: The aim study was to assess practices antipsychotic- induced hyperprolactinemia, in addition prevalence risk factors associated with it. Methods:: A retrospective cohort observational conducted among patients attending psychiatric clinics at an academic tertiary hospital Riyadh, Saudi...
Treatment and management of obesity is clinically challenging. The inclusion GLP-1 receptor agonists (GLP1RA) in the medical has proven to be efficacious. However, mechanisms underlying molecular changes arising from GLP1RA treatment patients with remain elucidated.
Liraglutide, a long-acting glucagon-like peptide-1 receptor agonist (GLP1RA), is well-established anti-diabetic drug, has also been approved for the treatment of obesity at dose 3 mg. There are limited number studies in literature that have looked changes metabolite levels before and after liraglutide patients with obesity. To this end, present study we aimed to explore plasma metabolomic profile, using liquid chromatography-high resolution mass spectrometry (LC-HRMS)
High-quality documentation is critical in medical settings for providing safe patient care. This study was done with the objective of assessing standard records anticoagulation clinics and investigating distinctions between notes written by pharmacists physicians.A retrospective cross-sectional analysis data from electronic health (EHRs) performed on patients who received were observed at October to December 2020. Patients monitored two clinics, one administered other physicians. The quality...
Abstract Disclosure: A.A. Alfadda: None. A. Masood: B.M. Alsuwayni: A.M. Alhossan: Background: Obesity is a chronic relapsing disease with multifactorial pathology. Chronic inflammation an important underlying cause, that also reason for development of obesity associated comorbidities including metabolic fatty liver disease. Medical management using glucagon-like peptide 1 (GLP-1) agonists has been effective in achieving weight loss and improvements glucose lipid control but effects on...